重肽鐵蛋白(FTH)多克隆抗體
Polyclonal Antibody to Ferritin, Heavy Polypeptide (FTH)
FTH1; FTHL6; PIG15; PLIF; Ferritin Heavy Chain; Apoferritin; Placenta Immunoregulatory Factor; Proliferation-Inducing Protein 15; Cell proliferation-inducing gene 15 protein
- 編號PAD021Eq01
- 物種Equus caballus; Equine (Horse，馬) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 774 ¥ 1806 ¥ 2580 ¥ 6450 ¥ 25800
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Western Blot; Samples: Lane1: Equine Liver lysate; Lane2: Equine Lung lysate; Lane3: Equine Kidney lysate;
Primary Ab: 0.15μg/ml Rabbit Anti-Equine FTH Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對FTH的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別FTH。
用法
Western blotting: 0.2-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Equus caballus; Equine (Horse，馬) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPD021Eq01 | 重肽鐵蛋白(FTH)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAD021Eq01 | 重肽鐵蛋白(FTH)多克隆抗體 | WB; IHC; ICC; IP. |
參考文獻
| 雜志 | 參考文獻 |
| PLoS One | Presence in the Pre-Surgical Fine-Needle Aspiration of Potential Thyroid Biomarkers Previously Identified in the Post-Surgical One [PubMed: PMC3765839] |
| Am J Physiol Lung Cell Mol Physiol. | Methemoglobin-induced signaling and chemokine responses in human alveolar epithelial cells [Pubmed:24142518] |
| J Alzheimers Dis | The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer’s Disease [PubMed: 26484920] |
| Eur Radiol | MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter [Pubmed:26960542] |
| Exp Hematol. | Impact of?TET2?deficiency?on?iron?metabolism?in?erythroblasts. [pubmed:28167288] |
留言咨詢
